Back to News
Market Impact: 0.35
The 'ChatGPT for doctors,' OpenEvidence, was valued at $15 billion in a new funding round
Source: businessinsider.com
Artificial IntelligenceHealthcare & BiotechPrivate Markets & Venture
Health AI startup OpenEvidence raised $250 million at a $15 billion valuation, according to people familiar with the matter. The financing underscores strong private-market investor appetite for clinical artificial-intelligence platforms, with OpenEvidence positioned as a "ChatGPT for doctors."
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.70
More News
- Trump, Xi Address AI, Taiwan During State Visit
- SEBI Allows Portfolio Managers to Invest Overseas, Short Equity Options
- China's Xi urges U.S. to cooperate on AI
- Oracle Japan shares surge 7% after record fiscal first quarter, bucking selloff of U.S. parent
- Surging Treasury yields are posing a brand new problem for Kevin Warsh and the Fed
- Trump Hosts China’s Xi With Trade, AI, Taiwan in Focus